In this study, we found that ailanthone exhibited potent antiproliferative ability against HCC by blocking PINK1-PRKN-mediated mitophagy, warranting further research into the combination of ailanthone and chemotherapeutic drugs. The gene discussed is PINK1; the disease is hepatocellular carcinoma.